Pancreatic Cancer Recurrence after Whipple
Hello. I had the Whipple surgery on 6/30/2020 for stage 3 Pancreatic cancer. I found out on 2/17/23 via CT scans that it is back in the pancreatitis bed and a noldule in my liver. I see my oncologist in 2 days to go over starting chemo again. I have back pain and abdominal pain from the recurrence. Has anyone had luck with chemo when the cancer returns? I hope the oncologist can get the tumor to shrink. I guess I am just looking for hope maybe this can get under control. Thank you.
Interested in more discussions like this? Go to the Pancreatic Cancer Support Group.
Connect

@katieliz Hi! My mom had platelets and RBC infusion fur to having to severe bleeding rather than just FOLFIRINOX causing it. What caused the bleeding is the hemorrhoids from severe diarrhea after 3rd round of chemo, and norovirus. She was on Eliquis for liver thrombosis which exacerbated this problem. Her levels are good now since they have platelets. Have they offered that to you?
P.s. I also come to read @stage4survivor ’s posts to induce a daily dose of positive reinforcement and hope.
-
Like -
Helpful -
Hug
1 Reaction@vp02 I also had low platelets and needed blood transfusion. Doc told me I had chemo induced colitis, which I got real crampy an had a lot of blood in stool. I am also on Elequis. So basically I think it’s the colitis to that sent me to hospital.
@stageivsurvivor What are your thoughts on Nalirifox vs Folfirinox? Same thing or better? Nalirifox is a chemotherapy regimen that consists of 4 different medicines, 3 of which are chemotherapy agents and one is similar to folic acid (from Drugs.com):
Onivyde (irinotecan liposomal), a chemotherapy agent encapsulated in a liposomal base to allow for more sustained blood levels of irinotecan
Oxaliplatin, another chemotherapy medicine that is a platinum-based alkylating agent that forms cross-links in DNA
Fluorouracil, an antimetabolite chemotherapy treatment that disrupts the formation of DNA
Leucovorin is a medicine similar to folic acid that is used to protect healthy cells from the side effects of chemotherapy agents.
Thanks!
@lvtexas There is no clinical trial data yet comparing (m)Folfirinox to Nalirifox. To get FDA approval, it had to be either less expensive treatment (which it is not) or be better than a regimen it is being compared to. Gemzar/Abraxane was selected as the comparator, the likelihood it would be proven better than if it went head-to-head against (m)Folfirinox which has been the “gold standard” since its FDA approval in 2018 and Folfirinox that was the gold standard from 2011-2018.